Description
CJC 1295 peptide is a synthetic growth hormone-releasing hormone (GHRH) analog used in laboratory research on pituitary signaling and growth hormone release. The No DAC form lacks the Drug Affinity Complex modification found in longer-acting variants, providing researchers with a distinct profile for studying signaling duration and endocrine response. CJC 1295 research also examines how peptide structure influences receptor activity, stability, and downstream GH-axis behavior.
CJC 1295 side effects vary with concentration, peptide form, and experimental conditions, so observed responses can differ across study models. This helps researchers compare compound-specific activity under controlled laboratory parameters.
Features
- Classification: GHRH-related research peptide
- DAC Status: No Drug Affinity Complex modification
- Research Pathway: GHRH receptor signaling
- Quantity: 10 mg research peptide
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary administration, consumption, diagnosis, treatment, or therapeutic use.
Reviews
There are no reviews yet.